3-, 8-substituted deuteroporphyrin derivatives, pharmaceutical agents that contain the latter, process for their production and their use in photodynamic therapy and MRI diagnosis

US6136841A · kind A · utility

Assignee

• SCHERING CORPORATION · US

Inventors

• Johannes Platzek · Berlin, DE
• Ulrich Niedballa · Berlin, DE
• Bernd Raduechel · Berlin, DE
• Wolfgang Ebert · Krefeld, DE
• Hanns-Joachim Weinmann · Berlin, DE
• Thomas Frenzel · Berlin, DE

Key dates

• Filing date: Jun 2, 1999
• Grant date: Oct 24, 2000
• Expiry date: Jun 2, 2019

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K49/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

3-,8-substituted deuteroporphyrin derivatives with various substituents in the 13- and 17-positions of the porphyrin skeleton are suitable as pharmaceutical agents for use in photodynamic therapy (PDT) and for MRI therapy monitoring.